SEC Form 4 · accession 0001140361-16-090420
ARDELYX, INC. · ARDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P. Rosenbaum
Officer — SVP, Drug Development
Period of report
Dec 16, 2016
Accepted (ET)
Dec 20, 2016 · 8:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001437402
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 16, 2016 | S | 900 | $14.4837 | D | 636 | I | See Footnote |
| Common Stock | holding | — | — | — | 22,144 | D | ||
| Common StockF2 | holding | — | — | — | 77,592 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares are directly held by the Reporting Person's wife.
- F2The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.